[go: up one dir, main page]

ES2098921T3 - Composiciones de cetoconazol de uso topico. - Google Patents

Composiciones de cetoconazol de uso topico.

Info

Publication number
ES2098921T3
ES2098921T3 ES94905058T ES94905058T ES2098921T3 ES 2098921 T3 ES2098921 T3 ES 2098921T3 ES 94905058 T ES94905058 T ES 94905058T ES 94905058 T ES94905058 T ES 94905058T ES 2098921 T3 ES2098921 T3 ES 2098921T3
Authority
ES
Spain
Prior art keywords
cetoconazole
compositions
topical use
glucorticosteroide
dermatologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94905058T
Other languages
English (en)
Inventor
Marc Karel Josef Francois
Alfons Jeanne Wouters
Gerard Frans Maria Cauwenbergh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2098921T3 publication Critical patent/ES2098921T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A COMPOSICIONES TOPICAS QUE CONTIENEN CETOCONAZOL, UNA ACETONIDA GLUCORTICOSTEROIDE Y UN PORTADOR ACEPTABLE DERMATOLOGICAMENTE CARACTERIZADO POR UN PH POR ENCIMA DE 2.5 Y POR DEBAJO DE 6, Y A UN METODO DE PREPARACION DE DICHA COMPOSICION.
ES94905058T 1993-01-21 1994-01-12 Composiciones de cetoconazol de uso topico. Expired - Lifetime ES2098921T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93200145 1993-01-21

Publications (1)

Publication Number Publication Date
ES2098921T3 true ES2098921T3 (es) 1997-05-01

Family

ID=8213579

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94905058T Expired - Lifetime ES2098921T3 (es) 1993-01-21 1994-01-12 Composiciones de cetoconazol de uso topico.

Country Status (19)

Country Link
US (1) US5654293A (es)
EP (1) EP0680328B1 (es)
JP (1) JP3918119B2 (es)
KR (1) KR100300525B1 (es)
CN (1) CN1096860C (es)
AT (1) ATE146965T1 (es)
AU (1) AU683865B2 (es)
CA (1) CA2153681C (es)
CY (1) CY2106B1 (es)
DE (1) DE69401336T2 (es)
DK (1) DK0680328T3 (es)
ES (1) ES2098921T3 (es)
FI (1) FI114009B (es)
GR (1) GR3022212T3 (es)
HK (1) HK1005999A1 (es)
HU (1) HU221319B1 (es)
NZ (1) NZ259866A (es)
RU (1) RU2126256C1 (es)
WO (1) WO1994016710A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2721212B1 (fr) * 1994-06-17 1996-09-13 Pf Medicament Composition et procédé d'obtention d'une émulsion de désonide.
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
FR2747568B1 (fr) * 1996-04-17 1999-09-17 Oreal Utilisation d'au moins un inhibiteur de lipoxygenase et d'au moins un inhibiteur de cyclo-oxygenase pour modifier la pousse des poils et/ou des cheveux
EP0872229A1 (en) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Compositions containing an antifungal and a phospholipid
EP1857113A3 (en) 1997-10-22 2007-12-19 Jens Ponikau USE OF ANTIFUNGAL AGENTS FOR THE TOPICAL TREATMENT OF asthma
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
GB9915625D0 (en) 1999-07-02 1999-09-01 Cortendo Ab Method
SE9902675D0 (sv) * 1999-07-12 1999-07-12 Astra Ab Pharmaceutical formulations, doses & regimens
GB2365770B (en) * 2000-08-18 2002-07-31 Diomed Dev Ltd Antifungal ketoconazole composition for topical use
CA2528776A1 (en) * 2002-10-24 2004-05-06 G & R Pharmaceuticals, Llc Antifungal formulations
DE102004014617A1 (de) * 2004-03-22 2005-10-13 Beiersdorf Ag Kosmetisches Produkt, umfassend eine thixotropiearme Öl-in-Wasser-Emulsion und einen transparenten Behälter
CA2566032A1 (en) * 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
DE102004032837A1 (de) * 2004-07-02 2006-02-09 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen
CN100418530C (zh) * 2005-04-06 2008-09-17 河南省眼科研究所 一种酮康唑滴眼液及其制造方法
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
WO2012177986A2 (en) 2011-06-22 2012-12-27 Vyome Biosciences Conjugate-based antifungal and antibacterial prodrugs
US9029342B2 (en) 2012-09-17 2015-05-12 Board Of Regents Of The University Of Texas System Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
AU2014276460A1 (en) 2013-06-04 2015-12-24 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
BE1022727B1 (nl) * 2015-04-20 2016-08-24 Stasisport Pharma Nv Fusidinezuur crème en methode voor het maken hiervan
CN107260656B (zh) * 2016-04-08 2021-02-09 湖北人福成田药业有限公司 地奈德乳膏及其制备方法
WO2018144841A1 (en) * 2017-02-03 2018-08-09 Board Of Regents, The University Of Texas System Topical voriconazole for the treatment of pain
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
CA3102288A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US11583488B2 (en) 2020-06-01 2023-02-21 The Procter & Gamble Company Method of improving penetration of a vitamin B3 compound into skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
AU1779192A (en) * 1991-04-11 1992-11-17 Drore Eisen Method of treatment using steroid mouthwash

Also Published As

Publication number Publication date
HUT73233A (en) 1996-07-29
CN1096860C (zh) 2002-12-25
FI114009B (fi) 2004-07-30
AU5883394A (en) 1994-08-15
HU9501959D0 (en) 1995-09-28
DE69401336D1 (de) 1997-02-13
AU683865B2 (en) 1997-11-27
CA2153681A1 (en) 1994-08-04
HK1005999A1 (en) 1999-02-05
WO1994016710A1 (en) 1994-08-04
CY2106B1 (en) 2002-04-26
GR3022212T3 (en) 1997-04-30
CA2153681C (en) 2004-05-25
JPH08505861A (ja) 1996-06-25
DK0680328T3 (da) 1997-01-20
ATE146965T1 (de) 1997-01-15
EP0680328A1 (en) 1995-11-08
KR100300525B1 (ko) 2001-10-22
RU2126256C1 (ru) 1999-02-20
FI953505A0 (fi) 1995-07-20
US5654293A (en) 1997-08-05
JP3918119B2 (ja) 2007-05-23
HU221319B1 (en) 2002-09-28
DE69401336T2 (de) 1997-04-24
EP0680328B1 (en) 1997-01-02
CN1116824A (zh) 1996-02-14
NZ259866A (en) 1999-07-29
FI953505L (fi) 1995-07-20

Similar Documents

Publication Publication Date Title
ES2098921T3 (es) Composiciones de cetoconazol de uso topico.
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
ES2195970T3 (es) L-ribavirina y usos de la misma.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
FI931031A0 (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
PT788356E (pt) Metodo e composicoes para a inibicao de proteina-quinases.
BG102259A (en) Compostions with controlled paroxetine release
AR001875A1 (es) Composición biocida que comprende una mezcla de uncompuesto de halopropinilo y una s-triazina que c ontiene azufre y método para proteger un sustrato de la infestación de hongos y algas
DE69625354D1 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
WO1992014696A3 (en) SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
GR3036159T3 (en) New compounds and compositions useful as antifungal and antimycobacterial agents.
BG103289A (en) Method for yohexene preparation
AR004476A1 (es) Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas
IL111791A0 (en) Glutaramide derivatives
NO923266L (no) Heksahydrobenzo(f)quinolinoner
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
GB1487796A (en) Perfuming agents containing sesquiterpenic derivatives
AU1235288A (en) Antidepressant compositions
KR920700608A (ko) 피부 외용제
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno
AR015458A1 (es) Compuestos de tetrahidrofurano, y composicion farmaceutica que lo contiene.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 680328

Country of ref document: ES